ADVERTISEMENT

India Pharma - IPM Growth Remains Moderate For Three Months Now In August: Motilal Oswal

Growth was mainly driven by price hikes.

<div class="paragraphs"><p>Colourful capsules arranged for photograph. (Source: Joshua Coleman /Unsplash)</p></div>
Colourful capsules arranged for photograph. (Source: Joshua Coleman /Unsplash)
BQ Prime’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BQ Prime’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
To continue reading this story
You must be an existing Premium User
OUR NEWSLETTERS
By signing up you agree to the Terms & Conditions of NDTV Profit